share_log

JMP Securities Maintains Market Outperform on Macrogenics, Lowers Price Target to $8

Benzinga ·  Jul 31 14:16  · Ratings

JMP Securities analyst Silvan Tuerkcan maintains Macrogenics (NASDAQ:MGNX) with a Market Outperform and lowers the price target from $16 to $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment